全文获取类型
收费全文 | 6131篇 |
免费 | 384篇 |
国内免费 | 65篇 |
专业分类
耳鼻咽喉 | 35篇 |
儿科学 | 135篇 |
妇产科学 | 143篇 |
基础医学 | 834篇 |
口腔科学 | 231篇 |
临床医学 | 518篇 |
内科学 | 1517篇 |
皮肤病学 | 159篇 |
神经病学 | 680篇 |
特种医学 | 214篇 |
外科学 | 604篇 |
综合类 | 10篇 |
一般理论 | 1篇 |
预防医学 | 334篇 |
眼科学 | 61篇 |
药学 | 430篇 |
中国医学 | 26篇 |
肿瘤学 | 648篇 |
出版年
2024年 | 15篇 |
2023年 | 99篇 |
2022年 | 225篇 |
2021年 | 328篇 |
2020年 | 206篇 |
2019年 | 269篇 |
2018年 | 261篇 |
2017年 | 184篇 |
2016年 | 220篇 |
2015年 | 237篇 |
2014年 | 276篇 |
2013年 | 372篇 |
2012年 | 528篇 |
2011年 | 499篇 |
2010年 | 259篇 |
2009年 | 232篇 |
2008年 | 404篇 |
2007年 | 369篇 |
2006年 | 351篇 |
2005年 | 269篇 |
2004年 | 269篇 |
2003年 | 214篇 |
2002年 | 188篇 |
2001年 | 32篇 |
2000年 | 19篇 |
1999年 | 32篇 |
1998年 | 32篇 |
1997年 | 16篇 |
1996年 | 13篇 |
1995年 | 15篇 |
1994年 | 15篇 |
1993年 | 11篇 |
1992年 | 17篇 |
1991年 | 7篇 |
1990年 | 15篇 |
1989年 | 14篇 |
1988年 | 10篇 |
1987年 | 6篇 |
1986年 | 5篇 |
1985年 | 4篇 |
1984年 | 3篇 |
1983年 | 7篇 |
1979年 | 4篇 |
1976年 | 2篇 |
1975年 | 2篇 |
1974年 | 2篇 |
1973年 | 4篇 |
1972年 | 3篇 |
1971年 | 4篇 |
1966年 | 2篇 |
排序方式: 共有6580条查询结果,搜索用时 15 毫秒
21.
Nocturnal frontal lobe epilepsy (NFLE) has become clinically relevant in recent years. NFLE represents a spectrum of clinical manifestations, ranging from brief, stereotyped, sudden arousals, often recurring several times per night, sometimes with a quasi-periodic pattern, to more complex dystonic-dyskinetic seizures and to prolonged "somnambulic" behaviour. Episodes of increasing intensity have been labelled as paroxysmal arousal (PA), nocturnal paroxysmal dystonia (NPD) and episodic nocturnal wandering (ENW). NFLE affects both sexes with a higher prevalence for men, is frequently cryptogenetic and displays a strong familial trait for parasomnias and epilepsy (NFLE). Seizures appear more frequently between 14 and 20 years of age, but can affect any age and tend to increase in frequency during life. Interictal and ictal scalp electroencephalography (EEG) are often normal, the use of sphenoidal leads may be helpful. Carbamazepine taken at night is often effective at low doses, but a third of the patients are resistant to anti-epileptic drugs (AED) treatment. A familial form, characterized by an autosomal dominant transmission, has also been described. Autosomal dominant nocturnal frontal lobe epilepsy is a genetic variant of NFLE, in itself both clinically and biologically heterogeneous. NFLE should be suspected in the presence of frequent stereotyped paroxysmal nocturnal motor events arising or persisting into adulthood. Videopolysomnography is mandatory to confirm the diagnosis. 相似文献
22.
Roberto Orecchia Umberto Veronesi Patrick Maisonneuve Viviana Enrica Galimberti Roberta Lazzari Paolo Veronesi Barbara Alicja Jereczek-Fossa Federica Cattani Claudia Sangalli Alberto Luini Pietro Caldarella Marco Venturino Daniele Sances Stefano Zurrida Giuseppe Viale Maria Cristina Leonardi Mattia Intra 《The lancet oncology》2021,22(5):597-608
23.
Emilio Bria MD Federica Cuppone MD Diana Giannarelli PhD Michele Milella MD Enzo Maria Ruggeri MD Isabella Sperduti PhD Paola Pinnarò MD Edmondo Terzoli MD Francesco Cognetti MD Paolo Carlini MD 《Cancer》2009,115(15):3446-3456
BACKGROUND:
To quantify the magnitude of benefit of the addition of hormone treatment (HT) to exclusive radiotherapy for locally advanced prostate cancer, a literature‐based meta‐analysis was conducted.METHODS:
Event‐based relative risks (RR) with 95% confidence intervals (CIs) were derived through a random‐effect model. Differences in primary (biochemical failure and clinical progression‐free survival) and secondary outcomes (cancer‐specific survival, overall survival [OS], recurrence patterns, and toxicity) were explored. Absolute differences and numbers of patients needed to treat (NNT) were calculated. A heterogeneity test, a metaregression analysis with clinical predictors of outcome, and a correlation analysis for surrogate endpoints were also performed.RESULTS:
Seven trials (4387 patients) were gathered. Hormone suppression significantly decreased both biochemical failure (RR, 0.76; 95% CI, 0.70‐0.82; P < .0001) and clinical progression‐free survival (RR, 0.81; 95% CI 0.71‐0.93; P = .002), with absolute differences of 10% and 7.7%, respectively, which translates into 10 and 13 NNT. cancer‐specific survival (RR, 0.76; 95% CI, 0.69‐0.83; P < .0001) and OS (RR, 0.86; 95% CI, 0.80‐0.93; P < .0001) were also significantly improved by the addition of HT, without significant heterogeneity, with absolute differences of 5.5% and 4.9%, respectively, which translates into 18 and 20 NNT. Local and distant relapse were significantly decreased by HT, by 36% and 28%, respectively, and no significant differences in toxicity were found. Primary and secondary efficacy outcomes were significantly correlated.CONCLUSIONS:
Hormone suppression plus radiotherapy significantly decreases recurrence and mortality of patients with localized prostate cancer, without affecting toxicity. Cancer 2009. © 2009 American Cancer Society. 相似文献24.
25.
26.
27.
Roberto Lorusso Samuel Heuts Federica Jiritano Roberto Scrofani Carlo Antona Guglielmo Actis Dato Paolo Centofanti Sandro Ferrarese Matteo Matteucci Antonio Miceli Mattia Glauber Enrico Vizzardi Sandro Sponga Igor Vendramin Andrea Garatti Carlo de Vincentis Michele De Bonis Silvia Ajello Giovanni Troise Margherita Dalla Tomba Filiberto Serraino 《Interactive Cardiovascular and Thoracic Surgery》2022,35(1)
Open in a separate window OBJECTIVESAlthough the intra-aortic balloon pump (IABP) has been the most widely adopted temporary mechanical support device in cardiac surgical patients, its use has declined. The current study aimed to evaluate the occurrence and predictors of early mortality and complication rates in contemporary cardiac surgery patients supported by an IABP.METHODSA multicentre, retrospective analysis was performed of all consecutive cardiac surgical patients receiving perioperative balloon pump support in 8 centres between January 2010 to December 2019. The primary outcome was early mortality, and secondary outcomes were balloon-associated complications. A multivariable binary logistic regression model was applied to evaluate predictors of the primary outcome.RESULTSThe study cohort consisted of 2615 consecutive patients. The median age was 68 years [25th percentile 61, 75th percentile 75 years], with the majority being male (76.9%), and a mean calculated 30-day mortality risk of 10.0%. Early mortality was 12.7% (n = 333), due to cardiac causes (n = 266), neurological causes (=22), balloon-related causes (n = 5) and other causes (n = 40). A composite end point of all vascular complications occurred in 7.2% of patients, and leg ischaemia was observed in 1.3% of patients. The most important predictors of early mortality were peripheral vascular disease [odds ratio (OR) 1.63], postoperative dialysis requirement (OR 10.40) and vascular complications (OR 2.57).CONCLUSIONSThe use of the perioperative IABP proved to be safe and demonstrated relatively low complication rates, particularly for leg ischaemia. As such, we believe that specialists should not be held back to use this widely available treatment in high-risk cardiac surgical patients when indicated. 相似文献
28.
29.
Paolo Gentileschi Leandro Siragusa Federica Alicata Michela Campanelli Chiara Bellantone Tania Musca Emanuela Bianciardi Claudio Arcudi Domenico Benavoli Bruno Sensi 《Nutrients》2022,14(14)
Introduction: Roux-en-Y gastric bypass (RYGB) and one anastomosis gastric bypass (OAGB) are two effective bariatric surgical procedures with positive outcomes in terms of weight loss, comorbidities remission, and adverse events profiles. OAGB seems to carry a higher risk of malnutrition, but existing data are controversial. The aim of this study is to objectively evaluate and compare malnutrition in patients undergoing RYGB and OAGB. Methods: Retrospective monocentric study of obese patients undergoing RYGB or OAGB between the 15 September 2020 and the 31 May 2021. Nutritional status was assessed using the Controlling Nutritional Status (CONUT) score and compared between groups. The primary outcome was the mean CONUT score at 6 months. The secondary outcomes included the incidence of malnutrition, comorbidities, including hypertension, insulin resistance and type II diabetes mellitus, and weight loss. Results: 78 patients were included: 30 underwent RYGB and 48 underwent OAGB. At 6-Month Follow-Up there was no difference between groups in the mean CONUT score nor in incidence of malnutrition. In both groups, the nutritional status significantly worsened 6 months after surgery (preoperative and postoperative score of 0.48 ± 0.9 and 1.38 ± 1.5; p = 0.0066 for RYGB and of 0.86 ± 1.5 and 1.45 ± 1.3; p = 0.0422 for OAGB). Type II Diabetes mellitus (DMII) and hypertension remission were significant in the OAGB group with a 100% relative remission in the DMII-OAGB group (p = 0.0265), and a 67% relative remission in the hypertension-OAGB group (p = 0.0031). Conclusions: No difference in nutritional status has been detected between patients undergoing RYGB or OAGB at the 6-Month Follow-Up. Both procedures may have significant mal-absorptive effects leading to decline in nutritional status. OAGB may be more efficacious in inducing DMII and hypertension remission. Larger prospective studies dedicated specifically to nutritional status after gastric bypass are needed to confirm the impact of different bypass procedures on nutritional status. 相似文献